Atlas Trials

Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics

Clinical trial NCT01001962 · UNKNOWN

Trial details

NCT number
NCT01001962
Sponsor
Aristotle University Of Thessaloniki
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HypertensionType II Diabetes
Start date
2016-01-01
Primary completion
2019-01-01
Enrollment
1054

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.